Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Neus Rabaneda-Lombarte, M.D., Ph.D.

Concepts (63)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Neus Rabaneda-Lombarte's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Neus Rabaneda-Lombarte has written about over time.
1-Methyl-4-phenylpyridinium, 1 publications between 2020 and 2020, average publication date June 2020. Antigens, CD, 1 publications between 2020 and 2020, average publication date June 2020. Interleukin-4, 1 publications between 2020 and 2020, average publication date June 2020. Membrane Glycoproteins, 1 publications between 2020 and 2020, average publication date June 2020. Pesticides, 1 publications between 2020 and 2020, average publication date June 2020. Drug Delivery Systems, 1 publications between 2021 and 2021, average publication date April 2021. Parkinsonian Disorders, 1 publications between 2021 and 2021, average publication date April 2021. Hospitals, Public, 1 publications between 2021 and 2021, average publication date June 2021. Microglia, 3 publications between 2020 and 2022, average publication date June 2021. Optic Atrophy, Hereditary, Leber, 1 publications between 2022 and 2022, average publication date July 2022. Silicon Dioxide, 1 publications between 2022 and 2022, average publication date August 2022. Back Pain, 1 publications between 2023 and 2023, average publication date August 2023. Colorectal Neoplasms, 1 publications between 2023 and 2023, average publication date August 2023. Hydronephrosis, 1 publications between 2023 and 2023, average publication date August 2023. Neuroleptic Malignant Syndrome, 1 publications between 2023 and 2023, average publication date August 2023. Pain, Intractable, 1 publications between 2023 and 2023, average publication date August 2023. Multiple Sclerosis, Relapsing-Remitting, 1 publications between 2024 and 2024, average publication date July 2024.

To see the data from this visualization as text, click here.
Rabaneda-Lombarte's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (63)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.